Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
J Psychopharmacol. 2021 Sep;35(9):1081-1090. doi: 10.1177/0269881121996890. Epub 2021 Mar 28.
The six-item version of the Positive and Negative Syndrome Scale (PANSS-6) has shown promise as a brief measure of the severity of core symptoms of schizophrenia. However, since all prior analyses of the PANSS-6 were based on data extracted from studies using the full 30-item PANSS (PANSS-30), it remains unknown whether it is possible to obtain valid information for the PANSS-6 ratings via a brief interview, such as the Simplified Negative and Positive Symptoms Interview (SNAPSI).
We aimed to validate the PANSS-6 ratings obtained via the SNAPSI using the PANSS-6 scores extracted from the PANSS-30 ratings obtained via the comprehensive Structured Clinical Interview for PANSS (SCI-PANSS) as the gold-standard reference.
The PANSS-6 ratings based on the SNAPSI and the PANSS-30 ratings based on the SCI-PANSS were conducted by independent raters with established inter-rater reliability.
Seventy-seven inpatients with schizophrenia ( = 35.1 ± 11.7 years; males = 57%; paranoid schizophrenia = 75%) participated in the study. The intraclass correlation coefficient (ICC) of the PANSS-6 total scores obtained using the SNAPSI and the PANSS-30-derived PANSS-6 total scores via the SCI-PANSS was 0.77 ( < 0.001). The ICC for the PANSS-6 total score and the PANSS-30-derived PANSS-8 (Andreasen's remission criteria) was 0.75 ( < 0.001). Spearman's rank correlation coefficient for changes in PANSS-6 total scores via the SNAPSI and changes in PANSS-30-derived PANSS-6 total scores was 0.70 ( < 0.001).
Using the SNAPSI to rate the PANSS-6 enables a focused and brief assessment of the severity of core symptoms of schizophrenia, which facilitates measurement-based care and clinical decision making in the treatment of schizophrenia.
阳性与阴性症状量表(PANSS)的六分量表版(PANSS-6)已被证明是一种评估精神分裂症核心症状严重程度的简短工具。然而,由于之前所有对 PANSS-6 的分析都是基于从使用完整的 30 项 PANSS(PANSS-30)的研究中提取的数据进行的,因此仍然不清楚是否可以通过简短的访谈(如简化的阳性与阴性症状量表访谈(SNAPSI))获得 PANSS-6 评分的有效信息。
我们旨在通过使用基于全面结构化临床访谈 PANSS(SCI-PANSS)的 PANSS-30 评分提取的 PANSS-6 评分作为金标准参考,来验证通过 SNAPSI 获得的 PANSS-6 评分。
由具有可靠内部一致性的独立评估者进行基于 SNAPSI 的 PANSS-6 评分和基于 SCI-PANSS 的 PANSS-30 评分。
共有 77 名住院精神分裂症患者(年龄=35.1±11.7 岁;男性=57%;偏执型精神分裂症=75%)参与了这项研究。使用 SNAPSI 获得的 PANSS-6 总分的组内相关系数(ICC)与通过 SCI-PANSS 从 PANSS-30 衍生的 PANSS-6 总分的 ICC 为 0.77(<0.001)。PANSS-6 总分与 PANSS-30 衍生的 PANSS-8(Andreasen 缓解标准)的 ICC 为 0.75(<0.001)。通过 SNAPSI 获得的 PANSS-6 总分的变化与通过 SCI-PANSS 从 PANSS-30 衍生的 PANSS-6 总分的变化之间的 Spearman 秩相关系数为 0.70(<0.001)。
使用 SNAPSI 对 PANSS-6 进行评分,可以对精神分裂症核心症状的严重程度进行重点和简短的评估,这有助于在精神分裂症的治疗中进行基于测量的护理和临床决策。